Microfluidic Electric-Field Immunoassay for Rapid Low-Abundance Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing immunoassays face challenges in sensitivity, assay time, and sample size, particularly in microfluidics-based protein detection, as proteins are diverse and often present in low abundance, necessitating improvements in speed and sensitivity without compromising simplicity or cost.
Innovation Solution
The development of an Electric Field Assisted Rapid Analyte Capture (EFARAC) immunoassay system using microfluidic devices with embedded electrodes to enhance antigen capture through lateral electric fields, enabling rapid analyte detection with electrochemiluminescence reactions and multiplexing capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional immunoassays are used for protein detection, then the assay can detect target proteins with high specificity, but the detection sensitivity is insufficient for low abundance proteins and the assay time is too long
Solution Approach 1:
The patent applies preliminary action by pre-functionalizing the microfluidic channel walls with capture antibodies before sample introduction. This pre-prepared binding surface enables immediate capture of target proteins as they flow through the channel, eliminating the need for separate incubation steps required in conventional immunoassays. The capture antibodies are covalently attached to the channel walls via epoxy-silane chemistry, creating a ready-to-use detection platform that significantly reduces assay time while maintaining high detection sensitivity for low abundance proteins.
Solution Approach 2:
The patent replaces the mechanical mixing and manual handling of conventional immunoassays with electrokinetic transport. By applying electric fields across the microfluidic channel, target proteins are rapidly transported to and captured by the immobilized antibodies on the channel walls. This electrical field-assisted capture mechanism substitutes for the time-consuming mechanical incubation and mixing steps, achieving both rapid analysis (minutes versus hours) and enhanced sensitivity through controlled, high-speed analyte delivery to binding sites.
2Quantity of substance
If microfluidics-based protein detection is used, then sample volume and reagent volume are reduced, but the detection sensitivity and assay speed are still insufficient
Solution Approach 1:
The patent applies parameter changes by modifying the physical and chemical parameters of the microfluidic system to enhance detection sensitivity. This includes optimizing the electrokinetic field strength, channel geometry, and antibody immobilization density to maximize capture efficiency. By adjusting these parameters, the system achieves high sensitivity detection of low abundance proteins in minute sample volumes, overcoming the limitation of conventional microfluidics that reduced sample volume but maintained insufficient detection capability.
3Ease of operation
If conventional ELISA systems are used, then the assay is simple to implement, but the throughput is low and the detection limit is not sufficiently low
Solution Approach 1:
The patent applies universality by designing a single microfluidic device that performs multiple functions: sample introduction, electrokinetic transport, antibody-mediated capture, and detection. This integrated platform maintains the simplicity of conventional ELISA by using the same antibody-antigen recognition chemistry, while simultaneously achieving high throughput through parallel processing of multiple samples and enhanced detection limits through electrokinetic concentration effects. The device can be configured for different analytes by simply changing the captured antibody, providing universal applicability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The EFARAC system achieves a 918-fold improvement in detecting human TNF-α concentration, reducing detection limits by 4-5 orders of magnitude, and allows for rapid analysis in under 30 minutes without molecular amplification, outperforming current ELISA and ECL systems in sensitivity and throughput.
Implementation Method 1
The EFARAC system achieves a 918-fold improvement in detecting human TNF-α concentration, reducing detection limits by 4-5 orders of magnitude, and allows for rapid analysis in under 30 minutes without molecular amplification, outperforming current ELISA and ECL systems in sensitivity and throughput.
Data Source
AI summary
In one embodiment, the present invention includes a system for detecting a target analyte which includes a microfluidic device having least one microfluidic channel with a binding surface positioned in the microfluidic channel with further include a first electrode and a second electrode. The system may further include a detector and a voltage supply. Also included is a method to detect a target analyte using a described microfluidics device, introducing solution with a target analyte to a binding surface, and binding the target analyte to the binding surface by applying an electrical potential between the first and second electrodes during at least a portion of the binding step, which enhances the rate of binding of the target analyte molecules to the binding molecules. The method then includes the steps of detecting a reporter molecule which corresponds to the amount of the bound target analyte molecules, which correlates with the amount of target analyte in the original sample. The method may also include multiple applications of sample to the binding surface prior to the detection step.